查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1607174

基因毒性測試市場：按產品、按應用分類 - 2025-2030 年全球預測

Genetic Toxicology Testing Market by Product (Assays, Reagents & Consumables, Services), Application (Cosmetics Industry, Food Industry, Healthcare Industry) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年基因毒性測試市場價值為15.1億美元，預計到2024年將達到16.5億美元，複合年成長率為10.38%，到2030年將達到30.3億美元。

基因毒性測試評估可能導致基因突變和染色體損傷的物質，為藥理學、環境安全和化學工業的風險評估提供重要資料。這項測試對於識別可能導致癌症的基因干擾劑、幫助遵守法規和確保公共至關重要。最終用途測試可應用於製藥、化妝品、農業和食品行業，以保護消費者免受潛在有害物質的侵害。嚴格的監管要求、遺傳安全意識的提高以及基於 CRISPR 的檢測等技術進步推動了市場成長。個人化醫療的興起進一步增加了對準確基因毒理學框架的需求。然而，高昂的成本和缺乏標準化程序構成了重大挑戰。該領域在體外模型與體內結果的預測準確性和檢驗面臨局限性，需要創新的研究解決方案。

主要市場統計
基準年[2023] 15.1億美元
預測年份 [2024] 16.5億美元
預測年份 [2030] 30.3億美元
複合年成長率（%） 10.38%

高通量篩檢方法和製程自動化的進步為提高效率和降低成本提供了機會。與科技公司合作開發強大的資料分析工具可以幫助簡化試驗解釋並加快監管提交。人工智慧和機器學習創新的市場也已經成熟，以提高遺傳毒性測試系統的預測能力。探索生物資訊學和計算毒理學將為遺傳風險評估提供更準確和客製化的方法。為了充分利用成長潛力，公司應投資開發支援多樣化測試應用、支援產業協作並促進透明和道德測試實踐的整合平台。此外，透過積極參與有關監管協調和道德考慮的討論，您可以使自己成為負責任創新的領導者。成功應對這些挑戰需要持續創新和對新技術的投資，以確保全面、準確和高效的檢測流程。

市場動態：揭示快速發展的基因毒性測試市場的關鍵市場洞察

供需的動態交互作用正在改變基因毒性測試市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 活性化藥品研發活動
    • 藥物發現和誘變劑鑑定的潛在需求
    • 反對藥品和化妝品的動物試驗
  • 市場限制因素
    • 缺乏技術精湛、經驗豐富的專業人員
    • 體內模型不足以研究複雜的終點
  • 市場機會
    • 人性化動物模型的需求不斷增加
    • 正在進行的研究工作旨在及早識別毒性
  • 市場挑戰
    • 關於在研究活動中道德使用動物的嚴格規則和規定

波特五力：駕馭基因毒性測試市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解基因毒性測試市場的外部影響

外部宏觀環境因素在塑造遺傳毒性測試市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解遺傳毒性測試市場的競爭格局

對基因毒性測試市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣遺傳毒性測試市場供應商的績效評估

FPNV定位矩陣是評估基因毒性測試市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了基因毒性測試市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，基因毒性測試市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：全面分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 活性化藥品研發活動
      • 藥物發現和誘變劑鑑定的潛在需求
      • 反對藥品和化妝品動物試驗
    • 抑制因素
      • 缺乏技術精湛、經驗豐富的專業人員
      • 體內模型不足以研究複雜的終點
    • 機會
      • 人性化動物模型的需求增加
      • 正在進行的早期識別毒性的研究活動
    • 任務
      • 關於在研究活動中道德使用動物的嚴格規則和規定
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 基因毒性測試市場：依產品

  • 化驗
  • 試劑/耗材
  • 服務

第7章 基因毒性測試市場：依應用分類

  • 化妝品產業
  • 食品工業
  • 醫療保健產業
  • 製藥/生物技術

第8章 北美和南美基因毒性測試市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區基因毒性檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲基因毒性檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
  • 戰略分析和建議

公司名單

  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Charles River Laboratories International, Inc.
  • Creative Bioarray
  • Creative Biolabs
  • Cyprotex PLC
  • Environmental Bio-Detection Products Inc.（EBPI）
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • Jubilant Life Sciences Limited
  • Merck KGaA
  • Nelson Laboratories, LLC
  • PerkinElmer Inc.
  • Shanghai Medicilon Inc.
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-DD6333AE5673

The Genetic Toxicology Testing Market was valued at USD 1.51 billion in 2023, expected to reach USD 1.65 billion in 2024, and is projected to grow at a CAGR of 10.38%, to USD 3.03 billion by 2030.

Genetic toxicology testing involves the assessment of substances that may cause genetic mutations or chromosomal damage, providing essential data for risk evaluation in pharmacology, environmental safety, and chemical industries. This testing is imperative as it identifies genetic disruptors that could lead to carcinogenesis, aiding regulatory compliance and ensuring public safety. Applications span pharmaceuticals, cosmetics, agriculture, and food industries where end-use testing protects consumers from potentially harmful substances. The market's growth is fueled by stringent regulatory demands, increasing awareness of genetic safety, and technological advancements like CRISPR-based assays. The rising development of personalized medicine further enhances the necessity for precise genetic toxicology frameworks. However, high costs and the lack of standardized procedures pose significant challenges. The field faces limitations in predictive accuracy and validation of in vitro models to in vivo outcomes, requiring innovative research solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 1.51 billion
Estimated Year [2024] USD 1.65 billion
Forecast Year [2030] USD 3.03 billion
CAGR (%) 10.38%

Opportunities lie in advancing high-throughput screening methodologies and automating processes to enhance efficiency and reduce costs. Collaboration with technology firms to develop robust data analytics tools can serve to streamline testing interpretations and facilitate regulatory submissions. The market is also ripe for innovations in artificial intelligence and machine learning to enhance the predictive capabilities of genetic toxicology testing systems. Exploring bioinformatics and computational toxicology can unlock more precise, tailored approaches to genetic risk assessments. To capitalize on growth potential, businesses should invest in developing integrated platforms that cater to diverse testing applications, support industry collaborations, and foster transparent, ethical testing practices. Moreover, engaging proactively in discussions about regulatory harmonization and ethical considerations will position companies as leaders in responsible innovation. Successfully navigating these challenges requires continuous innovation and investment in emerging technologies that ensure comprehensive, accurate, and efficient testing processes.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Genetic Toxicology Testing Market

The Genetic Toxicology Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising pharmaceuticals research and development activities
    • Potential demand in drug discovery and identification of mutagens
    • Opposition to animal testing of drugs and cosmetics
  • Market Restraints
    • Unavailability of skilled and experienced professionals
    • Inadequacy of in-vivo models to study complicated endpoints
  • Market Opportunities
    • Increasing demand for humanized animal model
    • Ongoing research activities for identifying toxicity at early stage
  • Market Challenges
    • Stringent rules and regulations for ethical use of animals in research activities

Porter's Five Forces: A Strategic Tool for Navigating the Genetic Toxicology Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Genetic Toxicology Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Genetic Toxicology Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Genetic Toxicology Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Genetic Toxicology Testing Market

A detailed market share analysis in the Genetic Toxicology Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Genetic Toxicology Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Genetic Toxicology Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Genetic Toxicology Testing Market

A strategic analysis of the Genetic Toxicology Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Genetic Toxicology Testing Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Charles River Laboratories International, Inc., Creative Bioarray, Creative Biolabs, Cyprotex PLC, Environmental Bio-Detection Products Inc. (EBPI), Eurofins Scientific SE, F. Hoffmann-La Roche AG, Jubilant Life Sciences Limited, Merck KGaA, Nelson Laboratories, LLC, PerkinElmer Inc., Shanghai Medicilon Inc., and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Genetic Toxicology Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Assays, Reagents & Consumables, and Services.
  • Based on Application, market is studied across Cosmetics Industry, Food Industry, Healthcare Industry, and Pharmaceutical & Biotechnology.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising pharmaceuticals research and development activities
      • 5.1.1.2. Potential demand in drug discovery and identification of mutagens
      • 5.1.1.3. Opposition to animal testing of drugs and cosmetics
    • 5.1.2. Restraints
      • 5.1.2.1. Unavailability of skilled and experienced professionals
      • 5.1.2.2. Inadequacy of in-vivo models to study complicated endpoints
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing demand for humanized animal model
      • 5.1.3.2. Ongoing research activities for identifying toxicity at early stage
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent rules and regulations for ethical use of animals in research activities
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Genetic Toxicology Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Assays
  • 6.3. Reagents & Consumables
  • 6.4. Services

7. Genetic Toxicology Testing Market, by Application

  • 7.1. Introduction
  • 7.2. Cosmetics Industry
  • 7.3. Food Industry
  • 7.4. Healthcare Industry
  • 7.5. Pharmaceutical & Biotechnology

8. Americas Genetic Toxicology Testing Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Genetic Toxicology Testing Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Genetic Toxicology Testing Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Bio-Rad Laboratories, Inc.
  • 3. Charles River Laboratories International, Inc.
  • 4. Creative Bioarray
  • 5. Creative Biolabs
  • 6. Cyprotex PLC
  • 7. Environmental Bio-Detection Products Inc. (EBPI)
  • 8. Eurofins Scientific SE
  • 9. F. Hoffmann-La Roche AG
  • 10. Jubilant Life Sciences Limited
  • 11. Merck KGaA
  • 12. Nelson Laboratories, LLC
  • 13. PerkinElmer Inc.
  • 14. Shanghai Medicilon Inc.
  • 15. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. GENETIC TOXICOLOGY TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. GENETIC TOXICOLOGY TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. GENETIC TOXICOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. GENETIC TOXICOLOGY TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GENETIC TOXICOLOGY TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GENETIC TOXICOLOGY TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY FOOD INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY HEALTHCARE INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. GENETIC TOXICOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. GENETIC TOXICOLOGY TESTING MARKET, FPNV POSITIONING MATRIX, 2023